Halder Venture Ltd — Important, 24-07-2026: Company Update

Halder Venture Limited has announced that its Board approved the allotment of 0.79 Cr equity convertible warrants on a preferential basis. These warrants, priced at Rs. 315 each (including a Rs. 305 premium) and a face value of ₹10, entitle the holder to equivalent equity shares. Allotted to non-promoter P.K. Bio Link Private Limited, the company has already received 25% of the subscription amount. This capital infusion strengthens Halder Venture's financial base, supporting operational activities and future growth initiatives.